HIMS
Get informed when a big investor buys or sells
+ FollowUndervalued by 225.2% based on the discounted cash flow analysis.
| Market cap | $6.23 Billion |
|---|---|
| Enterprise Value | $7.31 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.57 |
| Beta | 2.43 |
| Outstanding Shares | 231,746,126 |
| P/E Ratio | -45.43 |
|---|---|
| PEG | 14.99 |
| Price to Sales | 2.52 |
| Price to Book Ratio | 27.71 |
| Enterprise Value to Revenue | 2.84 |
| Enterprise Value to EBIT | -93.1 |
| Enterprise Value to Net Income | -52 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 5.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0674▼ 68.08% |
|---|---|
| Total Calls | 103,800▼ 99.72% |
| Total Puts | 7,000▼ 99.97% |
Holdings and activity of institutional investors.
| Ownership % | 0.21%▼ 69.13% |
|---|---|
| Total Invested | $14.30M▼ 99.74% |
| Investors Holding | 38▼ 548.00% |
No data
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...